1 – 50 of 95
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Overlaps and divergences between tauopathies and synucleinopathies : a duet of neurodegeneration
(
- Contribution to journal › Scientific review
-
Mark
Progressive QTc prolongation and reduced heart rate variability in dementia with Lewy bodies compared to Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Tau-neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum
(
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
(
- Contribution to journal › Article
-
Mark
Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns
(
- Contribution to journal › Article
-
Mark
Preventive cognitive protection based on AAV9 overexpression of IGF1 in hippocampal astrocytes
(
- Contribution to journal › Article
- 2023
-
Mark
Associations of phosphorylated tau pathology with whole-hemisphere ex vivo morphometry in 7 tesla MRI
(
- Contribution to journal › Article
-
Mark
Retardation of Aβ42 fibril formation by apolipoprotein A-I and recombinant HDL particles
(
- Contribution to journal › Article
-
Mark
The C-terminal domain of the antiamyloid chaperone DNAJB6 binds to amyloid-β peptide fibrils and inhibits secondary nucleation
(
- Contribution to journal › Article
-
Mark
Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors
(
- Contribution to journal › Article
-
Mark
Genetically identical twin-pair difference models support the amyloid cascade hypothesis
(
- Contribution to journal › Article
-
Mark
Severe CTE and TDP-43 pathology in a former professional soccer player with dementia : a clinicopathological case report and review of the literature
(
- Contribution to journal › Article
-
Mark
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients : A multi-cohort study
(
- Contribution to journal › Article
-
Mark
Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation
(
- Contribution to journal › Article
-
Mark
The chronic stress risk phenotype mirrored in the human retina as a neurodegenerative condition
(
- Contribution to journal › Article
- 2022
-
Mark
Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis
(
- Contribution to journal › Article
-
Mark
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
(
- Contribution to journal › Article
-
Mark
New hallmarks of ageing : a 2022 Copenhagen ageing meeting summary
(
- Contribution to journal › Article
-
Mark
Four Swedish cases of CSF1R-related leukoencephalopathy : Visualization of clinical phenotypes
(
- Contribution to journal › Article
-
Mark
Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes
(
- Contribution to journal › Scientific review
-
Mark
Does Loss of Integrity of the Cingulum Bundle Link Amyloid-β Accumulation and Neurodegeneration in Alzheimer's Disease?
(
- Contribution to journal › Article
-
Mark
Editorial : Genotype–phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The future of clinical trials for Alzheimer's disease. A blood-based biomarker perspective
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
(
- Contribution to journal › Article
- 2021
-
Mark
Impact of differential and time-dependent autophagy activation on therapeutic efficacy in a model of Huntington disease
(
- Contribution to journal › Article
-
Mark
Ex vivo MRI atlas of the human medial temporal lobe : characterizing neurodegeneration due to tau pathology
(
- Contribution to journal › Article
-
Mark
Derivation of Adult Human Cortical Organotypic Slice Cultures for Coculture with Reprogrammed Neuronal Cells
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases : An Overview
(
- Contribution to journal › Scientific review
-
Mark
A stress syndrome prototype reflects type 3 diabetes and ischemic stroke risk : The SABPA study
(
- Contribution to journal › Article
-
Mark
From iPS Cells to Rodents and Nonhuman Primates : Filling Gaps in Modeling Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Three-dimensional mapping of neurofibrillary tangle burden in the human medial temporal lobe
(
- Contribution to journal › Article
-
Mark
Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
(
- Contribution to journal › Article
-
Mark
Editorial : Regeneration and Brain Repair
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
(
- Contribution to journal › Article
- 2020
-
Mark
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein
(
- Contribution to journal › Article
-
Mark
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
(
- Contribution to journal › Article
-
Mark
Ultrastructural evidence for self-replication of alzheimer-associated Aβ42 amyloid along the sides of fibrils
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(21). p.11265-11273(
- Contribution to journal › Article
-
Mark
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course - A joint PhD student course at University College London and University of Gothenburg
(
- Contribution to journal › Scientific review
-
Mark
Animal models for preclinical Parkinson´s research: An update and critical appraisal
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Protein synthesis is suppressed in sporadic and familial Parkinson’s disease by LRRK2
(
- Contribution to journal › Article
- 2019
-
Mark
Long-Term, Targeted Delivery of GDNF from Encapsulated Cells Is Neuroprotective and Reduces Seizures in the Pilocarpine Model of Epilepsy
2019) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 39(11). p.2144-2156(
- Contribution to journal › Article
-
Mark
Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
(
- Contribution to journal › Article
-
Mark
The Fluid Percussion Injury Rodent Model in Preclinical Research on Traumatic Brain Injury
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Axonal degeneration is mediated by necroptosis activation
(
- Contribution to journal › Article
- 2018
-
Mark
Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism
(
- Contribution to journal › Scientific review
-
Mark
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease : Perspectives from the Research Roundtable
(
- Contribution to journal › Scientific review
-
Mark
Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(37). p.8765-8774(
- Contribution to journal › Article